MB-11362

• Description :

  MB-11362 is an orally active, selective HCV NS5B polymerase inhibitor and 4′-azidouridine triphosphate prodrug. MB-11362 can be converted to 4′-azidouridine triphosphate after oral administration. MB-11362 can be used in the research of HCV infection[1].

• Product Name Alternative :

  RG-7348

• UNSPSC :

  12352005

• Target :

  HCV

• Related Pathways :

  Anti-infection

• Field of Research :

  Infection

• Smiles :

  CCC(O[C@H]1[C@@H](OC(CC)=O)[C@H](N2C(NC(C=C2)=O)=O)O[C@@]1(COP3(O[C@H](C4=CC(Cl)=CC=C4)CCO3)=O)N=[N+]=[N-])=O

• Molecular Formula :

  C24H27ClN5O11P

• Molecular Weight :

  627.92

• References & Citations :

  [1]Coats SJ, et al. Chutes and ladders in hepatitis C nucleoside drug development. Antiviral Res. 2014 Feb;102:119-47.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1159183-97-7]